These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16614274)

  • 1. Economic evaluation of the impact of nicorandil in angina (IONA) trial.
    Walker A; McMurray J; Stewart S; Berger W; McMahon AD; Dargie H; Fox K; Hillis S; Henderson NJ; Ford I
    Heart; 2006 May; 92(5):619-24. PubMed ID: 16614274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management.
    IONA Study Group
    Heart; 2001 Jun; 85(6):E9. PubMed ID: 11359763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.
    IONA Study Group
    Lancet; 2002 Apr; 359(9314):1269-75. PubMed ID: 11965271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of nicorandil in angina: subgroup analyses.
    IONA Study Group
    Heart; 2004 Dec; 90(12):1427-30. PubMed ID: 15547020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
    IONA Study Group
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of nurse led intermediate care versus standard care for post-acute medical patients: cost minimisation analysis of data from a randomised controlled trial.
    Walsh B; Steiner A; Pickering RM; Ward-Basu J
    BMJ; 2005 Mar; 330(7493):699. PubMed ID: 15757959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial.
    Jones J; Wilson A; Parker H; Wynn A; Jagger C; Spiers N; Parker G
    BMJ; 1999 Dec; 319(7224):1547-50. PubMed ID: 10591720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris.
    Campbell HE; Tait S; Buxton MJ; Sharples LD; Caine N; Schofield PM; Wallwork J
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):312-8. PubMed ID: 11463549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
    Sani HD; Eshraghi A; Nezafati MH; Vojdanparast M; Shahri B; Nezafati P
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):401-6. PubMed ID: 25701829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study.
    Griffin SC; Barber JA; Manca A; Sculpher MJ; Thompson SG; Buxton MJ; Hemingway H
    BMJ; 2007 Mar; 334(7594):624. PubMed ID: 17339236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial.
    Sculpher M; Manca A; Abbott J; Fountain J; Mason S; Garry R
    BMJ; 2004 Jan; 328(7432):134. PubMed ID: 14711748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery.
    Zhao N; Xu J; Singh B; Yu X; Wu T; Huang Y
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010726. PubMed ID: 27488764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
    Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
    Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care.
    UK BEAM Trial Team
    BMJ; 2004 Dec; 329(7479):1381. PubMed ID: 15556954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost effectiveness analysis within a randomised controlled trial of post-acute care of older people in a community hospital.
    O'Reilly J; Lowson K; Young J; Forster A; Green J; Small N
    BMJ; 2006 Jul; 333(7561):228. PubMed ID: 16861254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
    Simpson D; Wellington K
    Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of ward based non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease: economic analysis of randomised controlled trial.
    Plant PK; Owen JL; Parrott S; Elliott MW
    BMJ; 2003 May; 326(7396):956. PubMed ID: 12727767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK.
    Stewart S; Murphy NF; Walker A; McGuire A; McMurray JJ
    Heart; 2004 Mar; 90(3):286-92. PubMed ID: 14966048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.